Use of Maxaquin in treatment of exacerbations of chronic bronchitis and focal pneumonias
About the Authors
V. E. NonikovRussian Federation
O. V. Makarova
Russian Federation
M. N. Zubkov
Russian Federation
E. N. Gugutzidze
Russian Federation
References
1. Jones R . Fluoroquinolone (lomcfloxacin ) International Suirveillance Trial: A Summary Report of over 30 Months оf Monitoring in V itro Activity / / International Symposium on New Quinolons, 4 -th , Abstracts.— Munich, 1992.— P . 20.
2. Jones R., Uoban D. Ofloxacin in Vitro Surveillance Studies in the United States and Canada : A Comparison Trial Utilizing Validated Results from over 50 Medical Centers / / Ibid .— P . 17.
3. King A., Phillips /., Amies S., Tillotson G. MICA udit of Routine C iprofloxacin Sensitivity Testing / / Ibid .— P . 15.
4. Tcikubo T. Annual Changes of the Susceptibility of Clinical Isolates to Ofloxacin / / Ibid .— P . 12.
5. The Quinolones / Ed. V.T .Andriole.— London: Academic P ress, 1988.
Review
For citations:
Nonikov V.E., Makarova O.V., Zubkov M.N., Gugutzidze E.N. Use of Maxaquin in treatment of exacerbations of chronic bronchitis and focal pneumonias. PULMONOLOGIYA. 1993:67-71. (In Russ.)